Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature

0301 basic medicine Medicine (General) 0303 health sciences QH301-705.5 Case Report Saccharomyces cerevisiae 3. Good health Saccharomyces boulardii 03 medical and health sciences Probiotic treatment R5-920 Intensive care unit Biology (General) Fungemia
DOI: 10.1016/j.mmcr.2017.02.002 Publication Date: 2017-02-23T00:01:02Z
ABSTRACT
Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing S. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We want to emphasize that physicians should be careful about probiotic usage in critically ill patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (40)